Back

Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up

2 September 2024 (08:00 - 08:40)
Organised by: Logo
Congress Presentation Part of: Electrical therapy in heart failure: what's new? Devices for Autonomic Modulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Dong Wang

Hannover Medical School, Hannover (Germany)

6 More presentations in this session

Presentation thumbnail
Clinical phenotypes in relation to outcomes in heart failure patients with cardiac resynchronization therapy and defibrillators (CRT-D): an unsupervised cluster analysis
Doctor L. Gerra (Piacenza, IT)
Abstract Slides Video
Presentation thumbnail
Electrical heart failure treatment in the Goldilocks zone: cardiac contractility modulation proves equally effective for heart failure control in HFrEF patients with mid-range QRS durations
Doctor C. Fastner (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
QRS complex fragmentation status before and after cardiac resynchronization therapy predicts hospitalizations for heart failure
Doctor C. Rodriguez-Lopez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of left ventricular lead position on echocardiographic response after upgrading from right to biventricular pacing - Insights from the BUDAPEST CRT Upgrade Trial
Professor B. Merkely (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmia characteristics after left ventricular assist device implantation
Doctor X. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Electrical therapy in heart failure: what's new?

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Session
Baroreflex activation therapy for HFrEF patients: long-term data and real-world experience
thumbnail
Congress Presentation
Real-world experience with baroreflex activation therapy
thumbnail
Congress Presentation
BeAT-HF: long-term safety profile and outcomes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources